This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

March 18, 2021
Delivered DigitallyCentral European Time

Enable Therapeutics

Profile

Enable Therapeutics is a clinical-stage biotechnology company that develops innovative biologics for the treatment of rare neurological and neuromuscular disorders. Our platform is based on a cell-penetrating antibody capable of delivering full-length protein or oligonucleotide cargo to the cytoplasm of cells that express the ENT2 transporter, which is highly upregulated in post-mitotic cells such as skeletal and cardiac muscle and the CNS.